Please ensure Javascript is enabled for purposes of website accessibility

Why Dynavax Stock Is Skyrocketing 45.8% This Week

By Keith Speights – Aug 27, 2021 at 6:01AM

Key Points

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of the company's partners launched its COVID-19 vaccine in Taiwan.

What happened

Shares of Dynavax Technologies (DVAX -0.69%) have skyrocketed 45.8% this week as of the market close on Thursday. Most of this big gain came after Dynavax's partner, Medigen, announced the launch of its COVID-19 vaccine MVC-COV1901 in Taiwan. Medigen's vaccine uses Dynavax's CpG 1018 adjuvant.

So what

The rollout of MVC-COV1901 is off to a fast start. Medigen stated that around 600,000 people were expected to receive its vaccine this week.

A person wearing a face mask holding a syringe and vaccine vial with a Taiwanese flag and coronavirus in the background.

Image source: Getty Images.

MVC-COV1901 received Emergency Use Authorization (EUA) in Taiwan last month for people 20 or older. The vaccine is administered in two doses, with the second dose given 28 days after the first dose.

Dynavax and Medigen announced a collaboration in July 2020 to develop a COVID vaccine using Dynavax's CpG 1018 adjuvant. (An adjuvant is an ingredient that boosts the immune response in vaccines.) Dynavax recorded $17.5 million in revenue from sales of CpG 1018 to Medigen in the first half of 2021. Its sales should increase significantly with MVC-COV1901 now on the market in Taiwan. 

Now what

Dynavax is definitely one of the top vaccine stocks to watch over the next few months. In addition to its collaboration with Medigen, its CpG 1018 adjuvant is being used by several other biopharmaceutical companies developing COVID vaccines.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Stocks Mentioned

Dynavax Technologies Stock Quote
Dynavax Technologies
DVAX
$11.53 (-0.69%) $0.08

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.